0001477584-15-000001.txt : 20150708
0001477584-15-000001.hdr.sgml : 20150708
20150707174333
ACCESSION NUMBER: 0001477584-15-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150708
DATE AS OF CHANGE: 20150707
EFFECTIVENESS DATE: 20150708
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarentis Therapeutics Inc
CENTRAL INDEX KEY: 0001477584
IRS NUMBER: 203505214
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-243210
FILM NUMBER: 15977392
BUSINESS ADDRESS:
STREET 1: 70 E 77TH ST APT 9C
CITY: NEW YORK
STATE: NY
ZIP: 10021
BUSINESS PHONE: (212) 861-6348
MAIL ADDRESS:
STREET 1: 70 E 77TH ST APT 9C
CITY: NEW YORK
STATE: NY
ZIP: 10021
D
1
primary_doc.xml
X0707
D
LIVE
0001477584
Sarentis Therapeutics Inc
70 E 77TH ST APT 9C
NEW YORK
NY
NEW YORK
10021
(212) 861-6348
DELAWARE
NOPCO INC
None
Corporation
true
Denise
Barbut
70 E 77TH ST APT 9C
New York
NY
NEW YORK
10021
Executive Officer
Director
Promoter
Pharmaceuticals
No Revenues
- 06b
false
2015-06-24
false
true
false
100000
1000000
750000
250000
false
1
0
0
0
Proceeds are for working capital. The number above excludes use of proceeds for normal salary and bonus to executive officers.
false
Sarentis Therapeutics Inc
/s/ Denise Barbut
Denise Barbut
President and CEO
2015-07-07